Navigation Links
ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease
Date:6/8/2009

IRVINE, Calif., June 8 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced positive results from a proof-of-concept Phase 2 clinical study in subjects with dry eye disease (keratoconjuctivitis sicca) using a new, proprietary, low-dose formulation of bromfenac, the active ingredient in Xibrom(R) (bromfenac ophthalmic solution) 0.09%. The study achieved statistical significance in the primary endpoint of the objective sign of conjunctival staining (Lissamine Green test) as compared to baseline. The study also achieved statistical significance on the objective sign of corneal staining (Fluorescein test) as compared to baseline. Patients also achieved statistically significant improvements in subjective symptoms measured by the Ocular Surface Disease Index (OSDI) and improvement in patients' most bothersome ocular symptoms.

"The strong clinical results from this proof-of-concept study further support our belief that a modified, low-dose formulation of bromfenac has the potential ability to effectively and conveniently treat signs and symptoms of dry eye disease and provide fast and sustainable relief for patients. Bromfenac's strong safety profile should support long-term treatment, which would be necessitated due to the chronic inflammatory nature of dry eye disease," stated Vicente Anido, Jr., Ph.D., President and Chief Executive Officer of ISTA Pharmaceuticals.

"ISTA is strongly committed to focusing on dry eye disease. The results of this study may help identify patients that would be most suitable for a larger, placebo-controlled study. These data come on the heels of our recently announced positive ecabet sodium Phase 2b study results in ISTA's dry eye franchise. We will analyze the data from both programs to determine which product candidate or candidates to move into further advanced stud
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting
2. Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
3. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
4. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
5. Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions
6. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
7. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
8. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
9. Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
10. Kinex Pharmaceuticals To Present at ASCO 2009 Annual Meeting
11. TRACON Pharmaceuticals Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... YORK and VIENNA , July ... at a press conference in New York ... PD01A, a vaccine against Parkinson,s disease. PD01A is the first ... to enter clinical testing. The Michael J. Fox ... $ 1.5 million grant, and presented at the press conference ...
(Date:7/31/2014)... AUSTIN, Texas , July 31, 2014 Vermillion, ... cancers and women,s health, will hold a conference call on ... discuss results for the second quarter ended June 30, 2014. ... to the call. Vermillion,s Chairman, President and CEO ... a question and answer period. Date: Thursday, August ...
(Date:7/31/2014)... July 31, 2014 The Galien Foundation today ... Galien USA Awards. The Prix ... and recognizes the technical, scientific and clinical research skills ... This year brings the highest number of nominees since ... . Nominees include biomedical products across three categories ...
Breaking Medicine Technology:First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5
... HEIGHTS, Ill., Nov. 1, 2011 When it comes to ... and determine the best course of treatment depends on the ... Palos Community Hospital offers patients the most advanced technology in ... is one of only two PEM scanners in the Chicagoland ...
... 1, 2011 Custom Spine unveils its new auxiliary connector ... an extension to the company,s ISSYS LP pedicle screw system, ... screw to be fully seated while maintaining full polyaxial motion ... is unique in its ability to accept multiple rod sizes ...
Cached Medicine Technology:Palos Offers New Technology in the Fight Against Breast Cancer 2Custom Spine Features Unique Auxiliary Connector System at NASS 2
(Date:7/31/2014)... been rising steadily in the U.S in recent years. ... Health, the number of individuals reporting past year heroin ... Emerging evidence suggests the increase may be linked to ... intranasal PO use to heroin use, with POs providing ... injection. This drug-use trajectory appears to have become ...
(Date:7/31/2014)... Ticket Down is a reliable source for ... Park in suburban Denver on Tuesday, September 9th. Over ... found a second home competing on American soil. They have ... friendly games and will look to have another successful experience ... Commerce City, Colorado. The match will be Mexico’s second of ...
(Date:7/31/2014)... developed a novel method for creating self-assembled protein/polymer ... living cells. The work offers a promising new ... tissue engineering applications. The findings were published in ... International Edition . , "We have demonstrated that, ... can form completely new types of aggregates. These ...
(Date:7/31/2014)... News) -- Preschoolers with special needs benefit from going ... according to a new study. Classmates with ... disabilities, researchers found. On the other hand, development of ... language skills, they said. "We were surprised to ... the end of the school year when considering those ...
(Date:7/31/2014)... Atlanta-based Jvion, a leader in clinical predictive algorithms ... predictive population health analytics as part of an ongoing ... healthcare. Ritesh Sharma, Jvion COO, commented, “it is critical ... the impact of and potential within predictive analytics. There ... good portion of it is conflicting or confusing. The ...
Breaking Medicine News(10 mins):Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 3Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 3Health News:Carnegie Mellon chemists create nanofibers using unprecedented new method 2Health News:Preschoolers With Special Needs May Gain From 'Inclusion' Classrooms 2Health News:Jvion Releases Top Three Lessons in Predictive Population Health Analytics 2Health News:Jvion Releases Top Three Lessons in Predictive Population Health Analytics 3
... Health Services Bring Better Quality of Care and ... April 15 Vocollect Healthcare Systems, Inc. and ... and management company for the long-term care, senior ... an agreement whereby Pathway Health Services will become ...
... Baptist ... the employee phase of the "Our House is Your House" ... Wilson Family Center for Good Grief as they have surpassed ... November of 2008, with 60 employee volunteers across the system ...
... been aroused in the identification and isolation of liver ... bone marrow cells have been found to have the ... immunological methods is difficult because of the complicated surface ... successful passage has been published., A research article to ...
... patients pick the tunes, study suggests , , WEDNESDAY, April 15 ... want to plug in that iPod or pop in a ... disease reduced their heart rates, breathing rate and blood pressure ... 23 previous studies found. , The report, published in the ...
... Delcath Systems, Inc. (Nasdaq: DCTH ) will ... Eastern Time on Wednesday, April 22, 2009. Richard Taney, ... host the call.(Logo: http://www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO ... may dial (888) 790-3326 (U.S./Canada) and use Conference Password: ...
... 15 Based on its recent analysis of ... tomography (CT) markets market, Frost & Sullivan recognizes ... Frost & Sullivan Award for Enabling Technology. Zecotek,s ... and solid-state photo detector technologies that will help ...
Cached Medicine News:Health News:Pathway Health Services and Vocollect Healthcare Systems Announce Strategic Partnership 2Health News:Baptist Colleagues Raise $1 Million for Baptist Trinity Hospice House and Kemmons Wilson Family Center for Good Grief 2Health News:Soothing Songs Please the Heart 2Health News:Delcath Systems to Host Quarterly Update Conference Call 2Health News:Frost & Sullivan Recognizes Zecotek Photonic's Medical Imaging Achievement, Development of Next-Generation Scintillation Crystals and Photo Detector Technology 2Health News:Frost & Sullivan Recognizes Zecotek Photonic's Medical Imaging Achievement, Development of Next-Generation Scintillation Crystals and Photo Detector Technology 3Health News:Frost & Sullivan Recognizes Zecotek Photonic's Medical Imaging Achievement, Development of Next-Generation Scintillation Crystals and Photo Detector Technology 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: